Significance of Increased SUV on PET Scan

Primary Clinical Significance

The American College of Radiology and other medical societies suggest that an increased SUV on PET scan indicates heightened metabolic activity, which most commonly suggests malignancy, but cannot reliably differentiate cancer from infection or inflammation without integrating clinical context, anatomical location, and visual interpretation by experienced readers 1, 2
In lymphoma, an SUVmax cutoff of 2.5 achieved 100% specificity and 86% sensitivity for detecting residual/recurrent disease in post-treatment settings, as recommended by the National Comprehensive Cancer Network 3, 4

SUV alone cannot reliably distinguish malignancy from infection, which is a critical clinical caveat, especially in tuberculosis-endemic regions where specificity plummets to 25% due to granulomatous disease mimicking malignancy 1, 2
Tuberculosis, sarcoidosis, rheumatoid nodules, and acute inflammation demonstrate markedly elevated SUV values that completely overlap with malignant ranges, highlighting the need for clinical correlation 1, 2
Post-treatment false positives can occur due to radiation-induced inflammation, postsurgical inflammation, recent chemotherapy, and growth factor use, which can cause false-positive bone marrow activation 1, 4

Primary lung tumors with SUVmax <3.0 predict low probability (8.8%) of lymph node metastases, according to the American College of Radiology 1
Pediatric bone sarcoma: SUVmax >1.0 combined with nodule diameter ≥6 mm differentiates benign from malignant pulmonary nodules with 92.1% accuracy, as recommended by the Children's Oncology Group 1
Richter's transformation: SUVmax ≥10 distinguishes transformation from chronic lymphocytic leukemia in patients not on kinase inhibitor therapy, according to the International Workshop on Chronic Lymphocytic Leukemia 1

Visual interpretation by experienced readers combined with quantitative SUVmax outperforms either method alone, achieving 96-100% sensitivity and 76-86% specificity, as recommended by the Society of Nuclear Medicine and Molecular Imaging 1, 5
Obtain tissue diagnosis when uncertainty exists, particularly in TB-endemic regions, regardless of SUVmax value, as recommended by the World Health Organization 1, 2

Strict adherence to predefined reconstruction algorithms and timing of PET imaging after FDG injection is required for SUV comparability across sites, as recommended by the European Association of Nuclear Medicine 3, 4
Changes in SUVmax >30% are required to confidently detect true progression or regression in individual patients in multicenter settings, according to the Response Evaluation Criteria in Solid Tumors (RECIST) 6